Where Pacira BioSciences Stands With Analysts
Where Pacira BioSciences Stands With Analysts
pacira biosciences分析師評級
The perception of Pacira BioSciences by financial...In the latest quarter, 12 analysts provided ratings for Pacira BioSciences (NASDAQ:PCRX), showcasing a mix of bullish and bearish perspectives.
在最新一季度，12位分析師對Pacira BioSciences（NASDAQ：PCRX）提供了評級，展現了看好和看淡的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $33.25, a high estimate of $57.00, and a low estimate of $10.00. A decline of 25.15% from the prior average price target is evident in the current average.
分析師通過他們對12個月價格目標的評估提供更深入的見解，顯示出平均目標爲$33.25，最高估計爲$57.00，最低估計爲$10.00。當前平均價格目標相對前期平均價格目標下降了25.15%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The perception of Pacira BioSciences by financial...
財務專家對Pa...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間